AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Recruitingn/aAges 18 Years - anyAllDr. Kerstin de Wit
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although the positive rate is low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging. A new tool (called Adjust-Unlikely) could safely reduce pulmonary embolism imaging in Canada. A research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Emergency department patient who is tested by an emergency physician for PE Exclusion Criteria: * Patient is \< 18 years of age * No documentation of whether PE is the most likely diagnosis * D-dimer is not tested or else not resulted during the emergency visit * The D-dimer level is known before documentation of whether PE is the most likely diagnosis * The D-dimer is ordered prior to the physician assessing the patient * The patient has previously registered that they opt out of all research at the participating site * The patient leaves against medical advice * The patient has had PE or deep vein thrombosis imaging (CT pulmonary angiogram, ventilation-perfusion scan or lower limb ultrasound) within prior 30 days * There is a new (non-PE) indication for anticoagulation * The patient was initiated on treatment for presumed PE prior to PE testing * The patient has previously been enrolled into the study * The patient has a prior history of lower extremity deep vein thrombosis without availability of a baseline ultrasound scan * The patient was transferred from another hospital organization * The patient does not reside in Ontario * The patient has no valid Ontario Health Insurance Plan card
๐Ÿ’Š

What it tests

  • Adjust-Unlikely
๐Ÿ“

Where

4 sites
Hamilton Health Sciences Corporation
Hamilton, Canada
Kingston Health Sciences Centre
Kingston, Canada
London Health Sciences Centre Research Inc
London, Canada
Ottawa Hospital Research Institute
Ottawa, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy